Claustral MeCP2 Regulates Methamphetamine-induced Conditioned Place Preference in Cynomolgus Monkey

Area of Science:

• Neuroscience
• Molecular Biology
• Addiction Research

Background:

• The claustrum, a brain nucleus, is implicated in reward processing and receives significant dopamine input.
• Methyl CpG-binding protein-2 (MeCP2) is a transcriptional regulator crucial for the dopaminergic reward system and drug addiction.
• MeCP2 is highly expressed in the claustrum, suggesting a potential role in its function related to addiction.

Purpose of the Study:

• To investigate the role of MeCP2 in the claustrum in regulating drug addiction.
• To explore how MeCP2 within the claustrum influences responses to addictive substances.

Main Methods:

• Established a non-human primate model to study methamphetamine (METH)-induced conditioned place preference (CPP).
• Utilized virus-mediated overexpression of MECP2 specifically in the claustrum.
• Conducted a CPP test following habituation and conditioning periods.

Main Results:

• Overexpression of MECP2 in the claustrum significantly reduced METH-induced CPP over three testing days.
• A decrease in visit scores to the METH-paired room was observed in the MECP2 overexpression group compared to controls.
• These findings indicate a modulatory effect of claustral MeCP2 on drug-associated behaviors.

Conclusions:

• The claustrum is identified as a critical brain region involved in drug addiction.
• MeCP2 in the claustrum appears to act as a mediator in regulating responses to addictive drugs like methamphetamine.
• These findings open avenues for therapeutic strategies targeting the claustrum and MeCP2 in addiction treatment.